Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • TOP STORY—Urethane Buyers Win $400 Million Jury Award in Trial of Price Fixing Claims Against Dow
    • ANTITRUST NEWS: Justice Department, Anheuser-Busch InBev, and Grupo Modelo Agree to Stay, Continue Discussions of Proposed Beer Merger
    • ANTITRUST—EDNY: Vitamin C Conspiracy Defendant’s Challenge to Piercing of Corporate Veil Barred as Untimely
    • ANTITRUST—NDCal: Class Members Held In Contempt For Failure to Appear for Depositions
    • CONSUMER PROTECTION—DMass: Vibram May Be Liable For Misrepresenting Health Benefits of Its Shoes
    • INDUSTRY NEWS: Thomas N. Hubbard to Consult for Charles River Associates
    • RICO—SDCal: Annuity Purchasers May Continue to Pursue Class Claims Against National Western Life Insurance
    • RICO—WDLa: Failure to Record Mortgage Assignment Does Not Support RICO Liability
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Antitrust Law Daily Wrap Up, CONSUMER PROTECTION—DMass: Vibram May Be Liable For Misrepresenting Health Benefits of Its Shoes, (Feb 21, 2013)

    Law Firms Mentioned:Cantor Colburn LLP | Milberg LLP
    Organizations Mentioned:Milberg, LLP | Vibram USA Inc.

    By Jody Coultas, J.D.

    Vibram USA Inc. may be liable for false and misleading marketing of its FiveFinger shoes under the Florida Deceptive and Unfair Trade Practices Act (DUTPA) and Massachusetts Consumer Protection Act (CPA) based on statements concerning the health bene ...

    By Jody Coultas, J.D.

    Vibram USA Inc. may be liable for false and misleading marketing of its FiveFinger shoes under the Florida Deceptive and Unfair Trade Practices Act (DUTPA) and Massachusetts Consumer Protection Act (CPA) based on statements concerning the health benefits of the shoes, according to the federal district court in Boston (Bezdek v. Vibram USA Inc., February 19, 2013, Woodlock, D.).

    Vibram’s FiveFingers shoes mimic barefoot running, while providing some protection against the elements. A purchaser claimed that Vibram’s advertising campaign was false and misleading because it misrepresented the health benefits of its shoes and that such benefits were scientifically proved in violation of the DUTPA and CPA.

    The purchaser’s allegations of falsity and deception were sufficient to state a claim, according to the court. In the complaint, the purchaser specifically identified several allegedly misleading statements as to the health benefits of wearing FiveFingers and specific dates on which these statements were made. Which statements influenced the purchaser’s decision was irrelevant because the purchaser was not required to prove actual reliance.

    A price premium injury was cognizable under the CPA and DUTPA, and the purchaser adequately pled such injury, according to the court. The purchaser’s alleged injury was economic loss from the fact that she would not have purchased FiveFingers if she had known the advertised health benefits were untrue. A review of Massachusetts and Florida law found that jurisdictions were willing to recognize price premium injury by current owners of a product whose value was artificially inflated by a deceptive act or practice at the time of purchase. The court declined to find the theory of injury too speculative but noted that it may be too difficult to determine the market value FiveFingers shoes have without their purported health benefits.

    The case is No. 12-10513-DPW

    Attorneys: Janine L. Pollack (Milberg LLP) for Valerie Bezdek. Andrew C Ryan (Cantor Colburn LLP) for Vibram USA Inc.

    Companies: Vibram USA Inc.

    Cases: ConsumerProtection Advertising StateUnfairTradePractices MassachusettsNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use